As of January 22, 2025, PDS Biotechnology (PDSB) has a market cap of $62.847 million USD. According to our data, PDS Biotechnology is ranked No.8021 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $62.85 M |
3.07%
|
Dec 31, 2024 | $60.98 M |
-67.20%
|
Dec 29, 2023 | $0.19 B |
-62.35%
|
Dec 30, 2022 | $0.49 B |
62.96%
|
Dec 31, 2021 | $0.30 B |
278.50%
|
Dec 31, 2020 | $80.06 M |
-19.25%
|
Dec 31, 2019 | $99.13 M |
-58.72%
|
Dec 31, 2018 | $0.24 B |
-96.57%
|
Dec 29, 2017 | $7.01 B |
-25.04%
|
Dec 30, 2016 | $9.35 B |
0.00%
|
Dec 31, 2015 | $9.35 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Market Cap | = | PDSB Stock Price | * | PDSB Shares Outstanding |
= | $1.68 | * | 37.41 M | |
= | $62.85 M |